Evidence map›Paper›PMID 17658518›Full record

ArticleFEBS letters2007

Inducible nitric oxide synthase (iNOS) mediates the early increase of blood supply (EIBS) in colon carcinogenesis.

Hemant K Roy, Ramesh K Wali, Young Kim, Yang Liu, John Hart, Dhananjay P Kunte, Jennifer L Koetsier, Michael J Goldberg, Vadim Backman

Open access · greenAbstract readComparative Study
In one paragraph

Article in FEBS letters, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy.Clinical cancer research : an official journal of the American Association for Cancer Research · 2010
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Hemant K RoyDepartment of Medicine, Feinberg School of Medicine at Northwestern University, Section of Gastroenterology, Evanston-Northwestern Healthcare, G208 Evanston Hospital, 2650 Ridge Avenue, Evanston, IL 60201, USA. h-roy@northwestern.edu
Ramesh K Wali
Young Kim
Yang Liu
John Hart
Dhananjay P Kunte
Jennifer L Koetsier
Michael J Goldberg
Vadim Backman
Northwestern University · USEvanston Hospital · USUniversity of Chicago Medical Center · US

Funding

Spectral Markers for Early Detection of Colon NeoplasiaU01CA111257 · NCI · NORTHSHORE UNIV HEALTHSYSTEM RES INST · PI BACKMAN, VADIM, ROY, HEMANT K. · 2004 to 2015
$6.0M
Spectroscopy of blood supply changes in early precancerR01CA109861 · NCI · NORTHWESTERN UNIVERSITY · PI BACKMAN, VADIM · 2005 to 2013
$1.7M
Mechanism of Increased Mucosal Blood Content as a Biomarker of Colon CancerR03CA119261 · NCI · NORTHSHORE UNIVERSITY HEALTHSYSTEM · PI WALI, RAMESH K · 2006 to 2007
$145k
NCI NIH HHS R01 CA109861NCI NIH HHS R01CA109861NCI NIH HHS R03 CA119261NCI NIH HHS R03CA119261NCI NIH HHS U01 CA111257NCI NIH HHS U01CA111257
6 · The paper itself

Abstract

We have recently demonstrated that dramatic alteration in mucosal microvascular blood content termed early increase in blood supply (EIBS) is a hallmark of early colon carcinogenesis. In the current study, we elucidate the mechanism of EIBS by assessing iNOS/nitric oxide axis in the histologically normal colonic mucosa of rats treated with the colon-specific carcinogen, azoxymethane. We demonstrate that there was a strong temporal correlation between EIBS and iNOS expression/activity. Importantly, we also observed that short-term treatment with nitric oxide inhibitor abrogated EIBS. These data indicate that iNOS induction may have a critical role in augmenting the predysplastic mucosal blood supply and thereby fostering colon carcinogenesis.

Indexed as

AnimalsAzoxymethaneCarcinogensColonic NeoplasmsEnzyme InhibitorsImmunohistochemistryLightMaleNG-Nitroarginine Methyl EsterNitric Oxide Synthase Type IIRatsRats, Inbred F344Scattering, RadiationTime FactorsAzoxymethaneCarcinogensEnzyme InhibitorsNG-Nitroarginine Methyl EsterNitric Oxide Synthase Type II

Identifiers

PMID17658518
PMCPMC2913280
OpenAlexW2087066272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.